250 related articles for article (PubMed ID: 35400249)
21. Bacteriophage endolysins as a novel class of antibacterial agents.
Borysowski J; Weber-Dabrowska B; Górski A
Exp Biol Med (Maywood); 2006 Apr; 231(4):366-77. PubMed ID: 16565432
[TBL] [Abstract][Full Text] [Related]
22. Genetic engineering of bacteriophages: Key concepts, strategies, and applications.
Hussain W; Yang X; Ullah M; Wang H; Aziz A; Xu F; Asif M; Ullah MW; Wang S
Biotechnol Adv; 2023; 64():108116. PubMed ID: 36773707
[TBL] [Abstract][Full Text] [Related]
23. Current Status of Endolysin-Based Treatments against Gram-Negative Bacteria.
Gontijo MTP; Jorge GP; Brocchi M
Antibiotics (Basel); 2021 Sep; 10(10):. PubMed ID: 34680724
[TBL] [Abstract][Full Text] [Related]
24. Bacteriophage genome engineering for phage therapy to combat bacterial antimicrobial resistance as an alternative to antibiotics.
Usman SS; Uba AI; Christina E
Mol Biol Rep; 2023 Aug; 50(8):7055-7067. PubMed ID: 37392288
[TBL] [Abstract][Full Text] [Related]
25. Bacteriophage endolysins as novel antimicrobials.
Schmelcher M; Donovan DM; Loessner MJ
Future Microbiol; 2012 Oct; 7(10):1147-71. PubMed ID: 23030422
[TBL] [Abstract][Full Text] [Related]
26. On the Occurrence and Multimerization of Two-Polypeptide Phage Endolysins Encoded in Single Genes.
Pinto D; Gonçalo R; Louro M; Silva MS; Hernandez G; Cordeiro TN; Cordeiro C; São-José C
Microbiol Spectr; 2022 Aug; 10(4):e0103722. PubMed ID: 35876588
[TBL] [Abstract][Full Text] [Related]
27. DUF3380 Domain from a Salmonella Phage Endolysin Shows Potent N-Acetylmuramidase Activity.
Rodríguez-Rubio L; Gerstmans H; Thorpe S; Mesnage S; Lavigne R; Briers Y
Appl Environ Microbiol; 2016 Aug; 82(16):4975-81. PubMed ID: 27287318
[TBL] [Abstract][Full Text] [Related]
28.
Abdelrahman F; Gangakhedkar R; Nair G; El-Didamony G; Askora A; Jain V; El-Shibiny A
Viruses; 2023 Feb; 15(2):. PubMed ID: 36851734
[TBL] [Abstract][Full Text] [Related]
29. Antimicrobial activity of prophage endolysins against critical Enterobacteriaceae antibiotic-resistant bacteria.
Gonçalves T; Marques AT; Manageiro V; Tanoeiro L; Vital JS; Duarte A; Vítor JMB; Caniça M; Gaspar MM; Vale FF
Int J Pharm; 2024 Feb; 651():123758. PubMed ID: 38160991
[TBL] [Abstract][Full Text] [Related]
30. Bacteriophage Endolysin: A Powerful Weapon to Control Bacterial Biofilms.
Liu B; Guo Q; Li Z; Guo X; Liu X
Protein J; 2023 Oct; 42(5):463-476. PubMed ID: 37490161
[TBL] [Abstract][Full Text] [Related]
31. Engineered endolysin-based "Artilysins" to combat multidrug-resistant gram-negative pathogens.
Briers Y; Walmagh M; Van Puyenbroeck V; Cornelissen A; Cenens W; Aertsen A; Oliveira H; Azeredo J; Verween G; Pirnay JP; Miller S; Volckaert G; Lavigne R
mBio; 2014 Jul; 5(4):e01379-14. PubMed ID: 24987094
[TBL] [Abstract][Full Text] [Related]
32. Characterization and Engineering Studies of a New Endolysin from the
Varotsou C; Premetis GE; Labrou NE
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239874
[TBL] [Abstract][Full Text] [Related]
33. Characterization of thermostable bacteriophage CPD2 and its endolysin LysCPD2 as biocontrol agents against
Shin D; Ha E; Kong M; Ryu S
Food Sci Biotechnol; 2023 Dec; 32(14):2069-2077. PubMed ID: 37860732
[No Abstract] [Full Text] [Related]
34. Recent trends in the use of bacteriophages as replacement of antimicrobials against food-animal pathogens.
Zia S; Alkheraije KA
Front Vet Sci; 2023; 10():1162465. PubMed ID: 37303721
[TBL] [Abstract][Full Text] [Related]
35. A Novel
Khan FM; Gondil VS; Li C; Jiang M; Li J; Yu J; Wei H; Yang H
Front Cell Infect Microbiol; 2021; 11():637313. PubMed ID: 33738267
[TBL] [Abstract][Full Text] [Related]
36. Endolysin, a Promising Solution against Antimicrobial Resistance.
Rahman MU; Wang W; Sun Q; Shah JA; Li C; Sun Y; Li Y; Zhang B; Chen W; Wang S
Antibiotics (Basel); 2021 Oct; 10(11):. PubMed ID: 34827215
[TBL] [Abstract][Full Text] [Related]
37. Endolysins as antimicrobials.
Nelson DC; Schmelcher M; Rodriguez-Rubio L; Klumpp J; Pritchard DG; Dong S; Donovan DM
Adv Virus Res; 2012; 83():299-365. PubMed ID: 22748813
[TBL] [Abstract][Full Text] [Related]
38. LysPBC2, a Novel Endolysin Harboring a Bacillus cereus Spore Binding Domain.
Kong M; Na H; Ha NC; Ryu S
Appl Environ Microbiol; 2019 Mar; 85(5):. PubMed ID: 30552194
[TBL] [Abstract][Full Text] [Related]
39. On the catalytic mechanism of bacteriophage endolysins: Opportunities for engineering.
Love MJ; Abeysekera GS; Muscroft-Taylor AC; Billington C; Dobson RCJ
Biochim Biophys Acta Proteins Proteom; 2020 Jan; 1868(1):140302. PubMed ID: 31678195
[TBL] [Abstract][Full Text] [Related]
40. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
Viertel TM; Ritter K; Horz HP
J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
